Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
600
Total enrollment
94
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.Alzheimer's diseasePh 3Completed600